I actually posted in the wrong spot...
I did read the Annual info form and found it quite interesting and it prompts me to ask 2 questions.
How many shareholders are aware two Executive Directors have recently "resigned"?
How many shareholders are aware that there has been a variation of 20-30% on the cost of developing Kapulo?
I won't make any secret of the fact I want out of these shares, it is just that I won't do it at over a 50% discount.
- Forums
- ASX - By Stock
- MWE
- ann fin report out 30mar - silence in here
MWE
mawson west ltd
ann fin report out 30mar - silence in here, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online